Skip to main content

ORIGINAL RESEARCH article

Front. Oncol.
Sec. Breast Cancer
Volume 15 - 2025 | doi: 10.3389/fonc.2025.1496592
This article is part of the Research Topic Challenges and Strategies in the Management of ER/PgR Low-Expression Breast Cancer: Exploring Fundamentals, Clinical Insights, and Treatment Approaches View all articles

Clinical Outcomes and Aesthetic Results of Reverse sequence Endoscopic versus Traditional Bilateral Nipple-Sparing Mastectomy with Immediate Implant-Based Breast Reconstruction-An Analysis of initial 116 patients from Single Institution

Provisionally accepted
Qing Zhang Qing Zhang 1LIANG Faqing LIANG Faqing 1Juan Li Juan Li 2Yanyan Xie Yanyan Xie 1Yu Feng Yu Feng 3Mengxue Qiu Mengxue Qiu 1Jiao Zou Jiao Zou 1Huanzuo Yang Huanzuo Yang 1Lv Qing Lv Qing 1Zhenggui Du Zhenggui Du 1*
  • 1 West China Hospital, Sichuan University, Chengdu, China
  • 2 Department of Breast Surgery, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China., Chengdu, China
  • 3 The Fourth People’s Hospital of Sichuan Province, Chengdu, Sichuan Province, China

The final, formatted version of the article will be published soon.

    Background: Endoscopic or robotic surgeries can minimize and hide the scars compared to conventional breast reconstruction but are considered unsuitable for bilateral procedures due to the extended operation time. This study explored a novel time-shortening endoscopic technique, namely reverse-sequence endoscopic nipple-sparing mastectomy (R-E-NSM) with bilateral implant-based breast reconstruction (BIBR), and compared it with conventional open surgery in clinical and cosmetic outcomes. Methods: We retrospectively analyzed patients who underwent BIBR in the West China Hospital from January 2017 to June 2022. Patient characteristics, operation time, postoperative complications, breast satisfaction, and Scar-Q scores were compared between endoscopic and conventional open groups. Results: Among 116 patients, 76 underwent R-E-NSM with BIBRs (R-E-BIBR group), and 40 underwent conventional open BIBRs (C-O-BIBR group). The demographics and clinicaldata were similar primarily (P > 0.05). Compared with the C-O-BIBR group, the R-E-BIBR group had lower rates of total (32.5% versus 6.6%, P < 0.001), major (13.8% versus 2.0%, P < 0.001) and minor (23.8% versus 3.9%, P < 0.001) complications. The operation time between the two groups is not statistically significant (290.2 ± 95.2 mins versus 271.9 ± 95.3 mins, P = 0.327). The Harris scale scored breast satisfaction, and the excellent rate of the C-O-BIBR group was 32.5% while the R-E-BIBR group was 58.0% (P < 0.001). The mean Scar-Q scores were 35.17± 9.6 in the C-O-BIBR group and 81.32 ± 12.3 in the R-E-BIBR group, respectively (P < 0.001).The innovative R-E-NSM with implant-based breast reconstruction makes up for the long operation time of previous endoscopic surgeries and has significant advantages in reducing complication rates and improving the cosmetic results of the postoperative breasts.

    Keywords: Level III, Retrospective study Implant-based Breast reconstruction, breast cancer, reverse-sequence, endoscopic nipple-sparing mastectomy

    Received: 14 Sep 2024; Accepted: 23 Jan 2025.

    Copyright: © 2025 Zhang, Faqing, Li, Xie, Feng, Qiu, Zou, Yang, Qing and Du. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Zhenggui Du, West China Hospital, Sichuan University, Chengdu, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.